Cost Curve News - News - https://www.costcurvenews.com/blog/

Putting All of the Pharm-to-Table Resources in One Place

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 days ago

Keep Reading

Cost Curve News

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 days ago

Keep Reading

Cost Curve News

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

4 days ago

Keep Reading

Cost Curve News

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 days ago

Keep Reading

Cost Curve News

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

6 days ago

Keep Reading

Cost Curve News

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 week ago

Keep Reading

Cost Curve News

PBMs Are Trying to Sell CMS on a ‘Splashy Announcement’ That PBMs Will (Voluntarily) Do the Right Thing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 week ago

Keep Reading

Cost Curve News

A New Antibiotic Might Make for the Most Interesting Pricing Story of the Year

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 weeks ago

Keep Reading

Cost Curve News

Injected Versions of Cancer Meds Make Life Easier for Patients and Drive Savings for Clinicians. There Is a Backlash Anyway

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 weeks ago

Keep Reading

Cost Curve News

It’s Formulary Season, and Early Analyses Suggest Big Changes in How PBMs Approach Biosims

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 weeks ago

Keep Reading

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

PBMs Are Trying to Sell CMS on a ‘Splashy Announcement’ That PBMs Will (Voluntarily) Do the Right Thing

A New Antibiotic Might Make for the Most Interesting Pricing Story of the Year

Injected Versions of Cancer Meds Make Life Easier for Patients and Drive Savings for Clinicians. There Is a Backlash Anyway

It’s Formulary Season, and Early Analyses Suggest Big Changes in How PBMs Approach Biosims

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Latest News

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

Subcribe To Newsletter